Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €588k |
| Net profit | €519k |
| Cash flow | €550k |
| Staff costs | €379k |
| Income taxes | €45k |
| Dividends | €1.00M |
| Total assets | €506k |
| Equity | €414k |
| Debt | €92k |
| of which ≤ 1y | €92k |
| of which > 1y | — |
| Working capital | €298k |
| Employees (FTE) | 4.7 |
| 2024 | |
|---|---|
| Current ratio | 4.24 |
| Quick ratio | 4.24 |
| Working capital ratio | 58.9% |
| Solvency | 81.8% |
| Debt / equity | 0.22 |
| Long-term debt ratio | — |
| Interest coverage | 554.92 |
| Gross margin | — |
| Net margin | — |
| ROA | 102.5% |
| ROE | 125.4% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €506k |
| Fixed assets | 21/28 | €116k |
| Intangible fixed assets | 21 | €104k |
| Tangible fixed assets | 22/27 | €10k |
| Financial fixed assets | 28 | €2k |
| Current assets | 29/58 | €391k |
| Amounts receivable within one year | 40/41 | €183k |
| Investments | 50/53 | €0 |
| Cash & bank | 54/58 | €204k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €506k |
| Equity | 10/15 | €414k |
| Contributions / capital | 10/11 | €1k |
| Accumulated profits (losses) | 14 | €413k |
| Amounts payable | 17/49 | €92k |
| Amounts payable within one year | 42/48 | €92k |
| Trade debts payable within one year | 44 | €3k |
| Income statement | ||
| Gross operating margin | 9900 | €968k |
| Operating result | 9901 | €557k |
| Financial income | 75 | €8k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €564k |
| Income taxes | 67/77 | €45k |
| Net result for the period | 9904 | €519k |
| Result to be appropriated | 9905 | €519k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →